These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20229247)

  • 1. Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.
    Chen TS; Liou SY; Wu HC; Tsai FJ; Tsai CH; Huang CY; Chang YL
    Int Urol Nephrol; 2011 Jun; 43(2):471-4. PubMed ID: 20229247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI).
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Hohenstein B; Julius U
    Atheroscler Suppl; 2017 Nov; 30():115-121. PubMed ID: 29096826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
    Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
    Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis.
    Chien CT; Chang WT; Chen HW; Wang TD; Liou SY; Chen TJ; Chang YL; Lee YT; Hsu SM
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1111-7. PubMed ID: 15072991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond lowering circulating LDL: apheresis-induced changes of systemic oxidative stress markers by four different techniques.
    Kopprasch S; Graessler J; Bornstein SR; Schwarz PE; Tselmin S; Frind A; Poberschin I; Julius U
    Atheroscler Suppl; 2009 Dec; 10(5):34-8. PubMed ID: 20129371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-apheresis: technical and clinical aspects.
    Bambauer R; Bambauer C; Lehmann B; Latza R; Schiel R
    ScientificWorldJournal; 2012; 2012():314283. PubMed ID: 22654591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patients.
    Kopprasch S; Bornstein SR; Schwarz PE; Bergmann S; Julius U; Graessler J
    Atheroscler Suppl; 2013 Jan; 14(1):157-60. PubMed ID: 23357158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flaxseed (
    Kanikowska D; Korybalska K; Mickiewicz A; Rutkowski R; Kuchta A; Sato M; Kreft E; Fijałkowski M; Gruchała M; Jankowski M; Bręborowicz A; Witowski J
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL apheresis in atherosclerotic disease with hyperlipidemia.
    Naganuma S; Agishi T; Ota K
    ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
    Vaziri ND; Navab K; Gollapudi P; Moradi H; Pahl MV; Barton CH; Fogelman AM; Navab M
    J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
    Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
    Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
    van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
    J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein apheresis: principles and indications.
    Winters JL
    Semin Dial; 2012; 25(2):145-51. PubMed ID: 22277063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term hazelnut consumption on DNA damage and oxidized LDL in children and adolescents with primary hyperlipidemia: a randomized controlled trial.
    Guaraldi F; Deon V; Del Bo' C; Vendrame S; Porrini M; Riso P; Guardamagna O
    J Nutr Biochem; 2018 Jul; 57():206-211. PubMed ID: 29753234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
    Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
    Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.